glucagon

Generic: glucagon

Labeler: fresenius kabi usa, llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name glucagon
Generic Name glucagon
Labeler fresenius kabi usa, llc
Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAMUSCULAR INTRAVENOUS
Active Ingredients

glucagon hydrochloride 1 mg/mL

Manufacturer
Fresenius Kabi USA, LLC

Identifiers & Regulatory

Product NDC 63323-596
Product ID 63323-596_eb37fc8a-a264-4ce9-a130-466e9b5f3a38
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA201849
Listing Expiration 2026-12-31
Marketing Start 2015-05-08

Pharmacologic Class

Classes
antihypoglycemic agent [epc] decreased gi motility [pe] decreased gi smooth muscle tone [pe] decreased glycolysis [pe] gastrointestinal motility inhibitor [epc] increased gluconeogenesis [pe] increased glycogenolysis [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 63323596
Hyphenated Format 63323-596

Supplemental Identifiers

RxCUI
310497
UPC
0363323596033
UNII
1H87NVF4DB

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name glucagon (source: ndc)
Generic Name glucagon (source: ndc)
Application Number NDA201849 (source: ndc)
Routes
INTRAMUSCULAR INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 1 mg/mL
source: ndc
Packaging
  • 10 VIAL, SINGLE-DOSE in 1 TRAY (63323-596-13) / 1 mL in 1 VIAL, SINGLE-DOSE (63323-596-11)
source: ndc

Packages (1)

63323-596-13 10 VIAL, SINGLE-DOSE in 1 TRAY (63323-596-13) / 1 mL in 1 VIAL, SINGLE-DOSE (63323-596-11)

Ingredients (1)

glucagon hydrochloride (1 mg/mL)

Linked Drug Pages (2)

Glucagon ndc-match (0.9) Glucagon ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "eb37fc8a-a264-4ce9-a130-466e9b5f3a38", "openfda": {"upc": ["0363323596033"], "unii": ["1H87NVF4DB"], "rxcui": ["310497"], "spl_set_id": ["e4be1c0e-0fe6-45a0-9229-5cde98434b84"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, SINGLE-DOSE in 1 TRAY (63323-596-13)  / 1 mL in 1 VIAL, SINGLE-DOSE (63323-596-11)", "package_ndc": "63323-596-13", "marketing_start_date": "20150508"}], "brand_name": "Glucagon", "product_id": "63323-596_eb37fc8a-a264-4ce9-a130-466e9b5f3a38", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Antihypoglycemic Agent [EPC]", "Decreased GI Motility [PE]", "Decreased GI Smooth Muscle Tone [PE]", "Decreased Glycolysis [PE]", "Gastrointestinal Motility Inhibitor [EPC]", "Increased Gluconeogenesis [PE]", "Increased Glycogenolysis [PE]"], "product_ndc": "63323-596", "generic_name": "Glucagon", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Glucagon", "active_ingredients": [{"name": "GLUCAGON HYDROCHLORIDE", "strength": "1 mg/mL"}], "application_number": "NDA201849", "marketing_category": "NDA", "marketing_start_date": "20150508", "listing_expiration_date": "20261231"}